A clinical trial comparing the pharmacokinetic characteristics and absolute bioavailability of injectable BJ007 (subcutaneous injection) formulation subcutaneously in healthy subjects using intravenous intravenous infusion of ceftriaxone sodium for injection as a control
Latest Information Update: 28 Jan 2026
At a glance
- Drugs Ceftriaxone (Primary) ; Ceftriaxone
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 28 Jan 2026 New trial record